Outcome
    Moderate Evidence
    Effectiveness 3/5

    Turkey Tail for Immune Function

    Standardized PSK and PSP extracts have real immune data — including survival meta-analyses as chemotherapy adjuncts in Japan — but the retail mushroom powder most people buy is not that product.

    Overview

    Standardized PSK and PSP extracts have real immune data — including survival meta-analyses as chemotherapy adjuncts in Japan — but the retail mushroom powder most people buy is not that product.

    Verdict

    Mixed evidence

    The pharmaceutical extracts earn a genuine yes; consumer-grade mycelium products have essentially no evidence behind them.

    How It Works

    PSK and PSP beta-glucans bind dectin-1 and TLR-2/4 on innate immune cells, increasing NK and cytotoxic T-cell activity and restoring lymphocyte counts.

    Dosing & Protocol

    Typical dose

    Recommended dose
    1-3 g/day standardized extract
    Expected timeframe
    8-12 weeks

    Protocol

    form
    Hot-water extract standardised for beta-glucan or PSK/PSP content; avoid mycelium-on-grain products, which are largely starch with little beta-glucan
    duration
    8-12 weeks
    co factor
    Take with food. Evidence is mixed. Turkey tail has the strongest oncology-adjacent evidence of any medicinal mushroom: PSK (krestin) is an approved adjuvant cancer treatment in Japan, with meta-analyses of gastric and colorectal cancer trials showing improved survival when added to chemotherapy, and PSP has trial data from China. Its immune effects operate through beta-glucan binding to dectin-1 and complement receptor 3 on innate immune cells. What is much thinner is evidence in healthy people: no good trial shows reduced infection frequency or improved immune outcomes in people without cancer.
    titration
    Increase to 3-9 g/day of extract; the Japanese oncology studies used PSK at 3 g/day
    starting dose
    1-3 g/day of Trametes versicolor extract with food

    Evidence

    What the studies say

    Meta-analyses of adjuvant PSK in gastric and colorectal cancer, pooling thousands of patients from Japanese trials, report absolute 5-year survival gains in the range of 8-9% when added to standard chemotherapy. A US phase I dose-escalation study in women recovering from breast cancer radiotherapy showed dose-dependent recovery of NK cell and lymphocyte counts at 6-9 g/day with no dose-limiting toxicity. Both bodies of evidence used hot-water-extracted, protein-bound polysaccharide preparations at gram doses. Most commercial turkey tail is mycelium grown on grain: beta-glucan is diluted by starch, batch-to-batch content is unverified, and no trial supports 500 mg capsules of it. Immune-marker changes also do not automatically mean fewer infections.

    TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy

    Score: 4/10
    2011
    observational

    Lu H, Yang Y, Gad E

    PSK activated natural killer cells via TLR2 and enhanced antibody-mediated antitumor effects

    View source

    Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: a meta-analysis of centrally randomized controlled clinical trials

    Score: 7/10
    2006
    meta_analysis
    n=1094

    Sakamoto J, Morita S, Oba K

    Adjuvant PSK improved overall and disease-free survival after curative colorectal cancer resection

    View source

    Phase 1 clinical trial of Trametes versicolor in women with breast cancer

    Score: 4/10
    2012
    rct
    n=11

    Torkelson CJ, Sweet E, Martzen MR

    Trametes versicolor was well tolerated up to 9 g/day with dose-dependent recovery of lymphocyte and natural killer cell counts

    View source

    Safety

    Caveats

    The gap between the oncology evidence and general immune support marketing is large: PSK adjuvant trials involved patients receiving chemotherapy for specific cancers under medical supervision, and none of that indicates benefit for healthy people trying to avoid colds. Anyone with cancer must discuss any mushroom product with their oncology team before use, since immunomodulators can interact with immunotherapy and chemotherapy - and PSK availability and formulation differ from consumer supplements. For general immune function the evidence sits with vaccination, sleep, exercise, not smoking, and correcting deficiencies of vitamin D, zinc, iron and protein. Recurrent severe or unusual infections warrant assessment for immunodeficiency, diabetes or HIV. Safety of turkey tail: generally well tolerated, with gastrointestinal upset, gas and darkened stools or nails reported. Caution applies in autoimmune disease and with immunosuppressants, since it stimulates immune activity. Product quality is a major issue - many products use mycelium grown on grain and contain little actual beta-glucan, so check for fruiting body extract with stated beta-glucan content. Safety in pregnancy and breastfeeding is not established.

    Less likely to help if

    Healthy people expecting fewer infections - the evidence does not extend there.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.